Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance Evaluation of Five Rapid At-Home COVID-19 Antigen Tests against the Omicron Variant.

Microbiology spectrum - 14 Feb 2023

Sugiharto Victor A, Gatrell Stephanie K, Chen Hua-Wei, Blazek Gabrielle R, Cherry Amanda M, Schilling Megan

Abstract excerpt

Rapid coronavirus disease 2019 (COVID-19) antigen tests can be used to aid in quickly identifying positive cases, which can help mitigate the spread of COVID-19 infection. Using previously characterized Omicron-positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), non-Omicron-positive SARS-CoV-2, and negative samples, we evaluated five brands of at-home rapid COVID-19 antigen tests (On/Go at-home...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Mutation
Share to Public Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 36519888
DOI: 10.1128/spectrum.02286-22
PMCID: PMC9927253

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance Evaluation of Five Rapid At-Home COVID-19 Antigen Tests against the Omicron Variant.PMID 36519888Read ↗

Performance of Three Rapid Antigen Tests Against the SARS-CoV-2 Omicron VariantSemantic proximity Read ↗

Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variantSemantic proximity Read ↗

Evaluation of the Panbio™ COVID-19 Antigen Rapid Diagnostic Test in subjects infected with Omicron using different specimensSemantic proximity Read ↗

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variantSemantic proximity Read ↗

Comparative performance of COVID-19 Test Methods in Healthcare Workers during the Omicron WaveSemantic proximity Read ↗

Retrospective and prospective studies evaluating the performance of the SARS-Cov-2 “AQ+ COVID-19 Ag Rapid Test” from InTec on symptomatic and non-symptomatic patientsSemantic proximity Read ↗

Detection of SARS-CoV-2 Omicron, Delta, Alpha and Gamma variants using a rapid antigen testSemantic proximity Read ↗

Real-life evaluation of a rapid antigen test (DPP® SARS-CoV-2 Antigen) for COVID-19 diagnosis of primary healthcare patients, in the context of the Omicron-dominant wave in BrazilSemantic proximity Read ↗

Sensitivity of rapid antigen tests for COVID-19 during the Omicron variant outbreakSemantic proximity Read ↗

OraSure InteliSwab™ Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and OmicronSemantic proximity Read ↗

Diagnostic Performance of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) Extension studySemantic proximity Read ↗

OraSure InteliSwab<sup>®</sup> Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and OmicronSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.